Now, investors of Clover Health (NASDAQ: CLOV) are grinning ear to ear. Although clov stock price today remains down greater than 25% year-to-date (YTD), shares of the company are up over 20% today.

Why precisely is Clover Wellness trading greater now?

Over the weekend, it was reported that Clover director Chelsea Clinton had just recently bought shares of CLOV stock. The transaction, which occurred on March 3, saw Clinton buy 100,000 shares for an average cost of $2.52 per share. In total amount, Clinton’s recent transaction totaled up to $252,530, according to a Type 4 submitted to the united state Securities as well as Exchange Commission (SEC).

Why Is CLOV Stock Up Today?
Right now, CLOV stock is up in response to Clinton’s acquisition, which investors are viewing as a favorable signal. Most of the times, supervisor trading activity such as this is necessary to track due to the fact that insiders commonly have a better sight of a business’s long-lasting growth potential than retail financiers.

So, with that said in mind, are various other insiders of Clover bullish on the firm? In the past twelve month, insiders have purchased 2.2 million shares as well as marketed 22.9 million shares. That’s a net of 20.6 million shares offered. This mass expert selling appears to correlate with CLOV stock’s decrease of greater than 60% over the past one year.

Still, with Clinton’s recent acquisition, investors are wondering who else is betting big on Clover Wellness. Allow’s jump right in.

That Else Is Betting Big on Clover Health?
Since the fourth quarter, 160 institutional capitalists own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) boost of 8.8%. Throughout the duration, the total amount of shares held by institutional financiers also boosted from 105.7 million to 129.8 million, up nearly 23% QOQ. Let’s have a look at the top 5 institutional shareholders.

Vanguard has 25.9 million shares or 7.65% ownership. The firm bought 8.8 million shares throughout Q4.
Greenoaks Funding Partners has 24.8 million shares or 7.34% ownership. The firm sold 24.8 million shares throughout Q4.
Baillie Gifford has 7.8 million shares or 2.3% ownership. The firm bought 2.6 million shares throughout Q4.
Two Sigma Investments has 6.6 million shares or 1.95% possession. The firm bought all 6.6 million shares during Q4.
PNC Financial Services (NYSE: PNC) possesses 6.4 million shares or 1.88% ownership. The firm marketed 249,850 shares throughout Q4.
Out of the top 5 investors, three funds decreased their settings as well as two funds enhanced their settings. Greenoaks Capital Allies had one of the most noteworthy purchase, as the fund marketed regarding 50% of its existing placement during Q4. 2 Sigma’s 6.6 million share purchase was likewise noteworthy, as the procurement put it among the leading five investors.